KRT7 and cancer: The expression of CDX2 in IHC sections is used in clinical pathology for the confirmation of the colonic origin of cancers in biopsies, usually in combination with cytokeratins CK20, which is usually co-expressed in the colon, and CK7, which is not expressed [26].